Centessa Pharmaceuticals plc (CNTA) Event June 30, 2022, 20:34 UTC 11 1 comments (99% Neutral) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Regulatory Update Comment Full text
ProQR Therapeutics (PRQR) Event June 30, 2022, 20:32 UTC 10 1 comments (99% Neutral) ProQR Therapeutics (PRQR) Announces 2022 Annual General Meeting Comment Full text
BeiGene Ltd (BGNE) Event June 30, 2022, 20:17 UTC 11 1 comments (90% Positive) BEIGENE, LTD. (BGNE) Provides Update on identified for tislelizumabCAMBRIDGE Comment Full text
Kiniksa Pharmaceuticals (KNSA) Event June 30, 2022, 20:13 UTC 12 1 comments (99% Neutral) Kiniksa Pharmaceuticals, Ltd. (KNSA) Announces Regulatory Update Comment Full text
Fate Therapeutics Inc (FATE) Event June 30, 2022, 20:06 UTC 11 1 comments (10% Negative) FATE THERAPEUTICS, INC. (FATE) Announces Delay in innovation Trials for Solid Tumors San Diego Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Curis Inc (CRIS) Event June 30, 2022, 20:05 UTC 11 1 comments (99% Neutral) CURIS INC (CRIS) Announces New Board Appointment Comment Full text
Pacific Biosciences of California Inc (PACB) Event June 30, 2022, 20:05 UTC 11 1 comments (99% Neutral) Pacific Biosciences of California, Inc. (PACB) Announces Business Combination Comment Full text
Blueprint Medicines Corp (BPMC) Event June 30, 2022, 20:05 UTC 11 1 comments (10% Negative) Blueprint Medicines Corporation (BPMC) Announces Business Combination Comment Full text
OncoCyte Corporation (OCX) Event June 30, 2022, 20:05 UTC 11 1 comments (99% Neutral) Oncocyte Corporation (OCX) Announces Executive Changes Comment Full text
Ascendis Pharma (ASND) Event June 30, 2022, 20:01 UTC 10 1 comments (99% Neutral) Ascendis Pharma (ASND) Files Form 6-K Comment Full text